Cargando…

Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale

The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotta, Ibolya, Kalcza-Janosi, Kinga, Szabo, Kinga, Marschalko, Eszter Eniko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928857/
https://www.ncbi.nlm.nih.gov/pubmed/34919494
http://dx.doi.org/10.1080/21645515.2021.2007708
_version_ 1784670729043705856
author Kotta, Ibolya
Kalcza-Janosi, Kinga
Szabo, Kinga
Marschalko, Eszter Eniko
author_facet Kotta, Ibolya
Kalcza-Janosi, Kinga
Szabo, Kinga
Marschalko, Eszter Eniko
author_sort Kotta, Ibolya
collection PubMed
description The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance.
format Online
Article
Text
id pubmed-8928857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89288572022-03-18 Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale Kotta, Ibolya Kalcza-Janosi, Kinga Szabo, Kinga Marschalko, Eszter Eniko Hum Vaccin Immunother Coronavirus – Research Paper The aim of the study was to develop and validate the Multidimensional Covid-19 Vaccine Hesitancy Scale (CoVaH), a self-report measure to assess the beliefs and attitudes beneath vaccination hesitancy and reasons for vaccine refusal in the context of Covid-19. A sample of 1503 Hungarian respondents filled out the scale. Exploratory and confirmatory factor analysis was conducted to identify latent constructs underlying participants′ responses. Findings show a robust three-factor solution for the 15-item CoVaH with high factor loadings on each factor: skepticism, risk perception and fear of Covid-19 vaccine. The CoVaH displayed very good fit indices (KMO = .94, RMSEA = 0.049, CFI = .983) and internal consistencies (α values > .89) and was found to have proper convergent, concurrent and discriminant validity in identifying Covid-19 vaccine hesitancy in the general population. The new scale adds to the literature through the identification of the fear of COVID-19 vaccines, as a newly highlighted explanatory variable of COVID-19 vaccine hesitancy, besides the other formerly identified components. The scale, available in English and Hungarian, allows the assessment of vaccine uptake hesitancy and has the potential to help targeted interventions, considering individual factors that interfere with vaccination acceptance. Taylor & Francis 2021-12-17 /pmc/articles/PMC8928857/ /pubmed/34919494 http://dx.doi.org/10.1080/21645515.2021.2007708 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Coronavirus – Research Paper
Kotta, Ibolya
Kalcza-Janosi, Kinga
Szabo, Kinga
Marschalko, Eszter Eniko
Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
title Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
title_full Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
title_fullStr Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
title_full_unstemmed Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
title_short Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
title_sort development and validation of the multidimensional covid-19 vaccine hesitancy scale
topic Coronavirus – Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928857/
https://www.ncbi.nlm.nih.gov/pubmed/34919494
http://dx.doi.org/10.1080/21645515.2021.2007708
work_keys_str_mv AT kottaibolya developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale
AT kalczajanosikinga developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale
AT szabokinga developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale
AT marschalkoesztereniko developmentandvalidationofthemultidimensionalcovid19vaccinehesitancyscale